Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 4 Glioma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Subclinical Breast Cancer Lesion 1 Recurrence 1 Prostatic Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Cranial Nerve Diseases 1 Childhood Brain Neoplasm 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adult Brain Glioblastoma 1

Interventions

Docetaxel 277 Prednisone 236 enzalutamide 175 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 153 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 78 abiraterone 75 gallium 68 PSMA-11 74 Specimen Handling 67 Gonadotropin-Releasing Hormone 58 darolutamide 56 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 49 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Gadolinium × Clear all

NCT01562223 2021-10-18

A6701QIBA

American College of Radiology Imaging Network

Phase NA Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡